TNFSF11 and osteoporosis: The main therapeutic strategies for osteoporosis comprise the use of anti-absorbents, such as bisphosphonates, selective estrogen receptor modulators (SERMs), and anti-receptor activators of nuclear factor kappa-B ligand (RANKL) antibodies [37].